Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge - Reuters

Reuters | July 29, 2025, 8:57 a.m. | Original
Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge Reuters
Microsoft in advanced talks for continued access to OpenAI tech, Bloomberg News reports - Reuters Wall St headed for higher open with focus on earnings, Fed meeting - Reuters